Lung cancer – Toripalimab Plus Chemo is Better than Chemo Alone
Background According to data from the CHOICE-1 trial, Toripalimab (anti–PD-1) in combination with chemotherapy showed significant improvement in the length of time until progression of the disease (Also called, Progression-Free…